Back to search
Post-Infarction Ventricular Septal Defect
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-Infarction Ventricular Septal Defect trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-Infarction Ventricular Septal Defect trials you may qualify forA single-arm, non-randomized, multi-center clinical study of the Amplatzer™ Trevisio™ Intravascular Delivery System for facilitating percutaneous, transcatheter…
FDA issued a Humanitarian Device Exemption (HDE) approval order for the AMPLATZER™ PIVSD Occluder (H070005) on January 10, 2017. The Conditions of Approval requ…